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Abstract
This study evaluated dietary intake in children with fetal alcohol spectrum disorders (FASD). Pre-
clinical research suggests that nutrient supplementation may attenuate cognitive and behavioral
deficits in FASD. Currently, the dietary adequacy of essential nutrients in children with FASD is
unknown. Dietary data were collected as part of a randomized, doubleblind controlled trial of
choline supplementation in FASD. Participants included 31 children with FASD, ages 2.5 – 4.9
years at enrollment. Dietary intake data was collected three times during the nine month study via
interview-administered 24-hour recalls with the Automated Self-Administered 24-hour Recall.
Dietary intake of macronutrients and 17 vitamins/minerals from food were averaged across three
data collection points. Observed nutrient intakes were compared to national dietary intake data of
children ages 2 – 5 years (What we Eat in America, NHANES 2007–2008) and to the Dietary
Reference Intakes. Compared to the dietary intakes of children in the NHANES sample, children
with FASD had lower intakes of saturated fat, vitamin D, and calcium. The majority (>50%) of
children with FASD did not meet the Recommended Dietary Allowance (RDA) or Adequate
Intake (AI) for fiber, n-3 fatty acids, vitamin D, vitamin E, vitamin K, choline, and calcium. This
pattern of dietary intake in children with FASD suggests that there may be opportunities to benefit
from nutritional intervention. Supplementation with several nutrients including choline, vitamin D,
and n-3 fatty acids, has been shown in animal models to attenuate the cognitive deficits of FASD.
These results highlight the potential of nutritional clinical trials in FASD.
Keywords
Fetal alcohol (FAS, FASD); Nutrition; Dietary intake
© 2013 Elsevier Inc. All rights reserved
Address Correspondence: Jeffrey R. Wozniak, Ph.D., Department of Psychiatry, University of Minnesota, F256/2B West, 2450
Riverside Ave., Minneapolis, MN 55454; jwozniak@umn.edu; Phone: 612-273-9741; Fax: 612-273-9779.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Conflict of Interest Statement
The authors have no competing interests.
NIH Public Access
Author Manuscript
Neurotoxicol Teratol. Author manuscript; available in PMC 2014 September 01.
Published in final edited form as:














Fetal alcohol spectrum disorders (FASD) is the largest known cause of intellectual disability
[1], and children with FASD exhibit life-long cognitive deficits and behavior problems [24].
FASD is a serious public health problem, affecting as many as 2–5% of young children in
the U.S. [17]. Effective interventions for these cognitive and behavioral deficits in FASD are
needed.
There are no biological treatments for the neurodevelopmental deficits in FASD. However,
animal models show that prenatal and postnatal dietary supplementation with specific
nutrients attenuates neurodevelopmental damage and improves cognitive outcomes in
offspring with prenatal alcohol exposure [11,22,25–27]. Translating pre-clinical nutritional
findings for interventions in human children presents several challenges, one of which is
controlling for the potentially confounding effects of dietary intake. Normal dietary intake
needs to be considered in determining the most effective and tolerable dosages for individual
nutrients and combinations of nutrients. Attention should be paid to nutrients that have
particularly large effects on early brain development [8,20] and are likely to be in deficit in
the FASD population. Identifying the latter was the goal of the current study.
In animal studies, supplementation is typically added to a standard adequate diet. These
studies assess the “added value” of supplemented nutrients. If diets of children with FASD
are deficient in key nutrients, a potential treatment would need to not only correct the dietary
deficiency but also provide additional supplementation for potential neurodevelopmental
benefit. The dietary requirements of many nutrients follow a U-shaped risk curve, with risks
for adverse outcomes highest with either deficient or excessive intakes [12]. The most
effective and safest dose will need to provide supplementation without exceeding tolerable
upper limits. Moreover, nutrient-nutrient interactions must be considered because they affect
bioavailability (absorption and utilization). For instance, choline and folate are involved in
methyl metabolism, and choline requirements increase during a folate deficiency [13].
Another example is that high doses of iron supplementation decrease zinc bioavailability
[12]. The fact that this is generally only seen with iron supplementation and not with normal
iron levels from a typical diet emphasizes the need for particular attention when
supplementing with large doses of a nutrient.
Currently, the adequacy of dietary intake is not known in FASD. Anecdotally, children with
FASD are often “picky eaters”, some have autistic-like taste and texture sensitivities, and
many have behavioral challenges such as rigidity and oppositionality. Also, many children
with FASD come from impoverished environments affected by alcoholism – environments
in which nutrition was inadequate and mealtimes were inconsistent and unpredictable
(factors that contribute to behavioral dysregulation around eating). These factors can result
in inadequate and unbalanced intakes of nutrients key for brain development and function.
The goal of this study was to evaluate the dietary intake of a representative sample of
children with FASD in the age range where supplementation might be beneficial in order to
determine the adequacy of intake of nutrients critical to brain development.
2. Methods
2.1 Participants
Participants included 31 children with FASD, ages 2.5 to 4.9 years at enrollment, who were
in a 9-month study of choline supplementation. Children were recruited from a University
FASD Clinic and an International Adoption Clinic (Table 1). Twenty-six participants were
living with adoptive families (6 international; 20 domestic), and five were with biological
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relatives. None were living with biological parents. The study took place between
September, 2009, and January, 2013. As part of clinical evaluations, children were seen by a
pediatric psychologist and a pediatrician with formal training in the University of
Washington diagnostic system for FASD [3]. Data on growth, facial dysmorphology,
cognition, and alcohol exposure were collected.
We applied modified Institute of Medicine (IOM) criteria [10] to data from clinic and the
baseline visit. If more than one growth, facial, or cognitive measurement was available, the
most severe measure was used. For FAS, criteria require dysmorphic facial features, growth
deficiency, and deficient brain growth. For Partial FAS, a dysmorphic face and either of the
following were required: growth deficiency or central nervous system (CNS) impairment as
defined by deficient brain growth or cognitive/behavioral impairment. For alcohol-related
neurodevelopmental disorder (ARND), confirmed exposure was required with CNS
impairment (deficient brain growth and/or cognitive/behavioral impairment). Of 31
participants, 7 (22.6%) met criteria for FAS; 12 (38.7%) for Partial FAS; and 12 (38.7%) for
ARND.
Growth deficiency was defined as height or weight ≤10%ile [15]; deficient brain growth was
defined as structural abnormalities and/or OFC ≤10%ile [29]; a dysmorphic face had at least
two features: short palpebral fissures (≤10%ile) [9], thin upper lip (rank 4 or 5 [3]), and
smooth philtrum (rank 4 or 5 [3]). Because IOM criteria do not quantify cognitive/
behavioral deficits, we applied Centers for Disease Control and Prevention (CDC) criteria,
specifying either global cognitive impairment >2 standard deviations (SD) or deficits of >1
SD in three or more domains (e.g., intellectual, language, motor, visual-perceptual, adaptive,
behavioral) [4]. Of 31 participants, 7 (35%) met CNS criteria based on brain growth, 20
(10%) had global cognitive impairment, and 19 (95%) had deficits in three or more domains
(1 did not have sufficient cognitive testing to judge this criteria, but met CNS criteria for
deficient brain growth). Seven participants (35%) met two or more CNS criteria.
Of 31 participants, 23 (74%) had confirmed prenatal alcohol exposure, including self-report
by the biological mother or social service records indicating heavy maternal use during
pregnancy. Inclusion required alcohol use consistent with Rank 3 or 4 in the Washington
system [3]. Examples included daily use throughout pregnancy, use to intoxication every
other day, or maternal intoxication at delivery. Minimal use, (e.g. occasional consumption of
<4 drinks, or without intoxication) did not meet criterion. Eight participants had only
“suspected” alcohol exposure, but met the criteria for FAS (n=1) or partial FAS (n=7). All 8
had dysmorphic faces and cognitive deficits as defined. In 22 cases, prenatal drug use was
suspected. In all cases, alcohol was the predominant substance of abuse and use was
extensive.
Exclusion criteria were presence of a developmental disorder (ex. Autism, Down
Syndrome), neurological disorder, traumatic brain injury, or other medical condition
affecting the brain. Psychiatric co-morbidity, such as attention deficit hyperactivity disorder
(ADHD), was not exclusionary as co-morbidity is high in FASD [21]. All but one
participant (a twin born at 36 weeks weighing 1360 grams) had a birthweight >1500 grams.
All procedures were approved by a University IRB and all participants underwent an
informed consent procedure.
2.2 Dietary Intake
Dietary intake data were collected three times during the 9-month study: at baseline, 6-
months, and 9-months into the study. Data were collected via interview-administered 24-
hour recalls using the Automated Self-Administered 24-hour Recall (ASA24) [19]. A
Fuglestad et al. Page 3













research assistant interviewed participants’ caregivers and entered dietary data into ASA24
during study visits. These data were collected during a trial of choline supplementation in
FASD. Only nutrient intake from food was included in the analysis; supplements, including
the choline supplement, were not included.
Primary measures included dietary intake of macronutrients and 17 vitamins/minerals. Mean
values for each nutrient were created from the three time points to create an observed daily
nutrient intake. Most participants (n=20) had three data points. For those with fewer data
points, means were from two dietary recalls (n=6) or a single dietary recall (n=5).
Observed nutrient intakes were compared using one-sample t-tests to national dietary intake
data from 24-hour dietary recalls of children ages 2–5 years (What we Eat in America,
National Health and Nutritional Examination Survey [NHANES] 2007–2008 [28]). The
dietary recalls for this study and for NHANES 2007–2008 used similar collection and
processing methods. Both were collected using the U.S. Department of Agriculture’s
(USDA) Automated Multiple-Pass Method during interview-administered 24-hour recalls.
Both datasets used the USDA’s Food and Nutrition Database for Dietary Studies, 4.1
(FNDDS 4.1) [2] to process the dietary intakes. Therefore the two datasets could be
compared to identify differences in dietary intake between children with FASD and similar-
age children. Although NHANES data were derived from single day dietary reports, daily
variation in intake was addressed by the inclusion of a large sample (N=832) and by
calculating nutrient totals using sample weights to account for differences in the day of the
week of the dietary recall. In the current study, we utilized three independent datapoints,
obtained over the course of the 9-month study, in order to address daily variability and to
increase the reliability of our measures.
To evaluate whether the observed nutrient intakes were adequate, data were compared to the
Dietary Reference Intakes (DRIs) [12]. DRIs are dietary recommendations established for a
given age range to meet or exceed the requirements of the majority of healthy children
within that age range. However, because there is individual variability in nutrient
requirements, the IOM provides guidelines [12]. The Recommended Dietary Allowance
(RDA) meets the nutritional needs of 97–98% of individuals and is the recommended intake.
Therefore, observed nutrient intakes above the RDA are considered likely adequate. The
Estimated Average Requirement (EAR) represents the median nutrient requirement, or the
intake that is adequate for 50% of individuals in a group. Observed nutrient intakes below
the EAR are considered likely inadequate. Conclusions about the adequacy of observed
intakes between the EAR (the adequate intake for 50% of individuals) and RDA (the
adequate intake for 97–98%) cannot be made; however, observed intakes in this range are
considered likely sub-optimal [12]. The EAR and RDA have not been established for several
nutrients due to insufficient data. For these nutrients, the adequate intake (AI) represents a
level that likely exceeds the actual (however unknown) requirements. Observed intakes
above the AI are considered likely adequate. We report only those nutrients for which the
majority of our sample (>50%) did not meet the RDA or AI.
2.3 Physical Growth
A physical examination was completed at baseline. Height-for-age z-score (HAZ), weight-
for-age z-score (WAZ), and weight-for-height z-score (WHZ) were calculated using EpiInfo
version 3.5.4 [5] with reference to CDC 2000 data for growth comparisons to U.S. children.
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Although children with FASD had comparable dietary intakes to similar-age children on
many nutrients, there were significant differences (Table 2). Children with FASD had lower
intakes of saturated fats, vitamin D, and calcium.
Based on the DRIs (Table 2), there was inadequate intake among children with FASD for
macronutrients, vitamins, and minerals. The majority of children did not have likely
adequate intakes (>AI) of total dietary fiber or poly-unsaturated fatty acids (PUFAs).
Specifically, most children (90%; n=28) did not meet the AI for total dietary fiber. Only one
participant (3%) had adequate intake (>AI) of n-3 fatty acids, and only half (52%; n=16) had
adequate intakes (>AI) of n-6 fatty acids.
In addition, inadequate intake was likely for 5 of 17 vitamins and minerals examined. The
majority had likely inadequate intakes (<EAR) of vitamins D and E. Specifically, none of
the participants met the EAR (10µg/d) for vitamin D. For vitamin E, 74% (n=23) did not
meet the EAR (1–3yrs: 5mg/d; 4–8yrs: 6mg/d), and only 13% (n=4) had likely adequate
intakes (>RDA). The majority did not have likely adequate intakes (>AI) of either vitamin K
or choline; 65% (n=20) did not meet the AI for vitamin K and 84% (n=26) did not meet the
AI for choline. Calcium was the only mineral of which the majority did not have likely
adequate intakes (>RDA). Seventy-four percent (n=23) did not meet the RDA for calcium,
with 35% (n=11) having likely inadequate intakes below the EAR (1–3yrs: 500mg/d; 4–
8yrs: 800mg/d). Although the majority had likely adequate intakes of iron, 32% (n=10) did
not meet the RDA.
Although dietary supplements were not included in the analysis, 52% (n=16) reported giving
their child at least one daily supplement at any time during the study. Daily supplements
included multivitamins (48%; n=15), omega-3 or fish oil (13%; n=4), vitamin D (7%; n=2),
calcium (7%; n=2), and iron (3%; n=1). Parents were asked to not add supplements
containing choline and no parent reported doing so during the study. After each dietary
recall, parents were asked whether food amounts reported were typical. Most (87%) were
described as typical, 10% were atypically low, and 3% were atypically high.
One sample t-tests compared the sample mean HAZ, WAZ, and WHZ to the U.S. reference
population (M=0). Our sample means did not differ from the reference population (Table 1)
for HAZ, t(30)=−1.37,p=0.182, WAZ, t(30)=−.35,p=0.732, or WHZ, t(30)=0.72,p=0.478.
To determine whether our dietary intake results were disproportionately affected by the
growth deficient children in our sample having lower nutrient intakes, the four participants
who were growth deficient were removed from analyses, and the results did not change.
There was no association between either age or gender and observed nutrient intakes.
Finally, given that the dietary intake data were collected as part of a choline intervention
study, we examined whether participants changed their diets over the duration of the study.
Repeated measures ANOVA revealed no change in dietary choline over the three dietary
recalls, F(2,38)= 0.564, p=.574. Although the study did not have the statistical power to
assess for potential changes in all of the nutrients of interest over the course of the study, it
is re-assuring that there were no changes in the principal nutrient under investigation.
4. Discussion
To our knowledge, this is the first study reporting on dietary intake of children with FASD.
Although they had similar caloric intakes to same-age children (NHANES), they had lower
consumption of saturated fats, vitamin D and calcium compared to NHANES, a pattern that
suggests they may be consuming fewer dairy products than similar-age children. Although
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deficient growth is a feature of FASD, our sample did not differ significantly in height or
weight from U.S. children; therefore, their dietary requirements should not differ from U.S.
standards.
Children with FASD did not meet the recommended intakes for several nutrients, and have a
dietary pattern that could benefit from improving intakes of dairy products, green leafy
vegetables, vegetable oils and nuts, as well as eggs and fish. Most (>50%) did not meet the
AI for fiber, n-3 fatty acids, vitamin K, or choline, or the RDA for vitamin D, vitamin E or
calcium. Specifically, only one child met the AI for n-3 fatty acids, all had inadequate
vitamin D, and 84% did not meet the AI for choline. Almost half did not meet the AI for n-6
fatty acids and nearly one-third were not meeting the RDA for iron. Other than calcium and
vitamin D, the intakes of these nutrients were similar to NHANES data, suggesting that low
intakes of these nutrients are not unique to children with FASD and may reflect a typical
American diet among children that includes many low-nutrient, energy-dense foods and
limited fruits, vegetables, and whole grains [6,7].
This diet profile in FASD, in which the intake does not meet adequacy for several nutrients
critical to brain development, suggests that nutritional intervention may have potential as a
component of treatment for these children. Several of the nutrients for which there was not
adequate intake have demonstrated relevance to cognition and behavior in pre-clinical
studies of FASD. For instance, supplementation in prenatally exposed animals with
postnatal choline attenuates memory deficits and reduces excess activity [22,25–27]; vitamin
D improves behavioral flexibility [11]; and n-3 fatty acids reduce oxidative damage in
hippocampus, prefrontal cortex (PFC), and cerebellum [22]. Other nutrients may also have
potential. For instance, nearly one-third of our sample did not meet the RDA for iron, a
nutrient that is important in early brain development – including postnatal brain
development [16].
The inadequate dietary patterns that we measured in children with FASD suggest that human
nutritional supplementation trials in FASD should incorporate doses that will both overcome
inadequate intakes and provide additional supplementation beyond the DRI. Preclinical data
suggest that there may be neurocognitive benefits of supplementation beyond merely
achieving sufficiency (typically, pre-clinical studies compare nutrient supplementation to a
control group fed a standard/adequate diet [11,22]). These benefits may have their effect
through two potential pathways in humans. The nutrient supplement may (1) change the
course or pathophysiology of FASD at the basic biochemical level (e.g., epigenetic
modification through choline supplementation) or (2) provide scaffolding for
neurodevelopment by ensuring that there is no additional pathology from nutrient deficits.
Adequate nutrition is critical during prenatal and early postnatal development when the CNS
is undergoing rapid changes [8,20]. In this study, we examined nutritional intake in children
ages 2.5 to 5 years. Prior to age 2 years, neurodevelopment is particularly active with peak
synaptogenesis and significant brain growth occurring by this age [20], and adequate
nutrition and supplementation may have its largest benefits during this time. However,
cortical synaptogenesis and myelination continue beyond age 2, particularly in regions of
higher cognitive functioning (e.g, PFC), and these neurodevelopmental processes may be
supported by nutrients such as choline and n-3 fatty acids which were low in our sample
[20]. Clearly, understanding patterns of nutrient intake among children with FASD at
different ages will be of added benefit. It will be important to determine the optimal
“windows” during which nutritional interventions will be most effective. As one example,
the window for choline in rat brain development appears to include gestation and at least the
first 30 postnatal days [18], corresponding to the first several years of human childhood. In
contrast, prenatal deficiencies of iron or zinc exacerbate the effects of prenatal alcohol
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exposure, suggesting that adequate amounts of these nutrients during gestation play a
protective role against the teratogenic effects at the time of exposure [14,23].
A potential limitation of the current study is the reliance on interview-administered 24-hour
recalls as opposed to extensive food diaries. However, these data match the NHANES data,
which were also 24-hour recall data. For most participants, we averaged data from three
time points, increasing reliability. Another potential limitation relates to individual
variability in nutrient requirements – making determinations of “adequacy” difficult;
however the observed nutrient intakes were evaluated in accordance with the IOM
recommendations for using DRIs [12].
In conclusion, the pattern of dietary intake we measured in children with FASD suggests
that there are opportunities for nutritional intervention and highlights the need for clinical
supplementation trials in neurodevelopmental disorders like FASD. Based on the
developmental window during which various nutrients are effective in pre-clinical models,
the fact that early human childhood represent a period of intense brain development, and
evidence of inadequate intake of key nutrients, nutritional supplementation in young
children appears to have significant potential for neurodevelopmental interventions in
FASD.
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• Children with FASD have lower intakes of vitamin D and calcium compared to
national dietary intake data from similar-age children.
• Children with FASD are not consuming recommended intakes of vitamin D,
choline, and n-3 fatty acids, nutrients important for neurodevelopment.
• The dietary pattern in children with FASD highlights the potential for nutritional
supplementation to provide scaffolding for improving neurobehavioral
functioning.
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Table 1
Participant characteristics at baseline
N(%) or mean (SD) N=31
Age (years) 4.11 (0.71)
Gender
  Male 11 (35.5%)
  Female 20 (64.5%)
Anthropometry/physical growth
  Height-for-Age z-Score −0.22 (0.89)
  Weight-for-Age z-Score −0.07 (1.10)
  Weight-for-Height z-Score 0.13 (1.01)
Dysmorphic Facial Features
  Lip (rank 4 or 5) 13 (42%)
  Philtrum (rank 4 or 5) 15 (48%)
  Palpebral Fissure (≤10th percentile)a 19 (61%)
≥2 Facial Features Present 13 (42%)
Growth Deficiency (≤10th percentile)
  Height 3 (10%)
  Weight 4 (13%)
Deficient Brain Growth (≤10th percentile)
  Occipital-Frontal Circumference 3 (10%)
Alcohol/Drug Exposure
  Alcohol Confirmed 23 (74%)
  Alcohol Suspected 8 (26%)
  Other Drug Exposure Suspected 22 (71%)
IOM Diagnostic Category
  FAS 7 (23%)
  Partial FAS 12 (39%)
  ARND 12 (39%)
Baseline Cognitive Functioning (Mullen Scalesb)
  Visual Reception 46.8 (15.3)
  Fine Motor 42.4 (13.2)
  Receptive Language 43.5 (10.9)
  Expressive Language 41.4 (9.1)
  Early Learning Composite 88.1 (18.9)
a
Missing for one participant from whom an accurate measure could not be obtained (n=30).
b
The individual scales of the Mullen Scales of Early Learning (Visual Reception, Fine Motor, Receptive Language, and Expressive Language)
use a t-score distribution (M=50SD=10). The Early Learning Composite Score is on a scale with a mean of 100 (SD=15).
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